3.73
-0.09 (-2.36%)
-0.09 (-2.36%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd | GLMD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.09 | -2.36% | 3.73 | 09:57:58 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.9797 | 3.70 | 4.03 | 3.82 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.72 | 3.86 | 0.14 | - | 1 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 201 | 102,681 | $ 3.86 | $ 396,351 | 163,510 | 2.96 - 6.4378 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:57:56 | 100 | $ 3.73 | USD |
Galmed Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 78.75M | 21.11M | 17.58M | $ - | $ - | -0.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Galmed Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.7889 | 4.03 | 3.57 | 3.76 | 174,014 | -0.0589 | -1.55% |
| 1 Month | 3.28 | 4.03 | 3.05 | 3.47 | 137,891 | 0.45 | 13.72% |
| 3 Months | 3.17 | 4.32 | 2.96 | 3.51 | 125,456 | 0.56 | 17.67% |
| 6 Months | 4.52 | 5.50 | 2.96 | 3.73 | 95,970 | -0.79 | -17.48% |
| 1 Year | 5.64 | 6.4378 | 2.96 | 4.24 | 92,623 | -1.91 | -33.87% |
| 3 Years | 11.11 | 27.06 | 2.96 | 10.38 | 158,894 | -7.38 | -66.43% |
| 5 Years | 7.48 | 27.06 | 2.78 | 9.64 | 113,689 | -3.75 | -50.13% |
Galmed Pharmaceuticals Description
| Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. |
